Skip to main content

Dan Silverstein

Analyst

UBS

Equibles does not estimate personal net worth.

About Dan Silverstein

Dan Silverstein is recorded as Analyst at UBS. Dan Silverstein has spoken on 11 earnings calls across 3 companies, most recently for Sleep Number Corp on May 12, 2026. Those appearances were for Somnigroup International Inc. (SGI), Purple Innovation, Inc. (PRPL) and Sleep Number Corp (SNBRQ). The companies whose calls Dan Silverstein spoke on are classified in the Consumer Cyclical sector.

Dan Silverstein on recent calls

“Amy, could you just provide detail around your liquidity position as of today? And if Memorial Day kind of went to plan, which it sounds like April is trending in line with expectations, what would that mean for the cash flow dynamics in the second quarter?”
Analyst — UBS, Q1 2026 Sleep Number Corporation Earnings Conference Call ·
“Could we please double click on Mattress Firm's performance year to date? How has store traffic and ticket evolved over the last few months? And then on margins, what are some of the promotional investments you are making and how are you balancing the flow through of margins against driving additional share gains?”
Analyst — UBS, Somnigroup International Inc. Q1 FY2026 Earnings Call ·
“And I'll just start by saying, Todd, great working with you, and best of luck in your next role. Just to start, no problem, on the sales guidance, can you just clarify, just to make sure, Is anything changing from an underlying demand perspective, or it's just the reporting adjustment?”
Analyst — UBS, Purple Innovation, Inc. Q1 FY2026 Earnings Call ·
“Maybe just to start looking at the sales guidance, up $30 to $50 million this year. I think the mattress firm expansion was supposed to drive around $70 million of additional sales, and it sounds like it's doing really well right off the gate.”
Analyst — UBS, Purple Innovation, Inc. Q4 FY2025 Earnings Call ·
“So with the new product launches, what were the main pain points you were trying to address? and then the comfort mode product replaced its predecessor at a higher margin how will this new announcement today how will these new beds reset you know the impact on asps cost per bed and margins going forward thank you sure…”
Analyst — UBS, Q4 & FY 2025 Sleep Number Corporation Earnings Conference Call ·

Affiliation history

  • UBS

    Analyst

    Source not stated

    Current

Company network

Recent activity